title: Interaction between allergy and innate immunity: model for eosinophil regulation of epithelial cell interferon expression.
abstract: BACKGROUND
  Eosinophils in asthmatic airways are associated with risk of exacerbations. The most common cause of asthma exacerbations is viral respiratory infections, particularly human rhinovirus (HRV).
  
  
  OBJECTIVE
  To determine the mechanism by which eosinophils may influence virus-induced responses.
  
  
  METHODS
  We used an in vitro coculture model of primary human eosinophils and the BEAS-2B epithelial cell line either stimulated with HRV1A infection or polyinosinic-polycytidylic acid (poly[I:C]). The messenger RNA (mRNA) expression of interferon (IFN) β1 and IFN-λ1 was assessed by quantitative reverse-transcriptase polymerase chain reaction and the protein level of IFN- λ1 by enzyme-linked immunosorbent assay.
  
  
  RESULTS
  Both poly(I:C) and HRV1A infection induced BEAS-2B expression of IFN-β1 and IFN-λ1 mRNA. Coculture of eosinophils resulted in suppression of poly(I:C)-stimulated IFN-β1 and IFN-λ1 mRNA expression (2.5-fold and 3.6-fold less, respectively). Separation of cells did not block eosinophil regulatory activity. Coculture of eosinophils with HRV1A-infected BEAS-2B cells also suppressed IFN-β1 and IFN-λ1 mRNA (5.7-fold and 5.0-fold less, respectively) and reduced IFN-λ1 protein secretion (1.6-fold decrease). This corresponded to a 34% increase in the quantity of HRV1A virus RNA on coculture with eosinophils. Recombinant transforming growth factor β suppressed IFN-λ1 from HRV1A-infected BEAS-2B cells. Coculture of eosinophils and BEAS-2B cells induced transforming growth factor β secretion, which may mediate suppression of HRV-induced interferon expression.
  
  
  CONCLUSIONS
  Eosinophils suppressed HRV-induced expression of interferons from epithelial cells, resulting in increased quantity of HRV. This represents one mechanism for interaction between allergic inflammation and innate immunity.
authors.affiliation: Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA. sm4@medicine.wisc.edu
authors.forename: Sameer K
authors.initials: SK
authors.lastname: Mathur
authors.forename: Paul S
authors.initials: PS
authors.lastname: Fichtinger
authors.forename: John T
authors.initials: JT
authors.lastname: Kelly
authors.forename: Wai-Ming
authors.initials: WM
authors.lastname: Lee
authors.forename: James E
authors.initials: JE
authors.lastname: Gern
authors.forename: Nizar N
authors.initials: NN
authors.lastname: Jarjour
mesh_terms: D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000276:immunology; D002460:Cell Line; D018920:Coculture Techniques; D004804:Eosinophils / Q000276:immunology* / Q000378:metabolism; D004847:Epithelial Cells / Q000276:immunology* / Q000378:metabolism; D005260:Female; D006801:Humans; D007113:Immunity, Innate; D016899:Interferon-beta / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D007372:Interferons; D007378:Interleukins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010850:Picornaviridae Infections / Q000276:immunology; D011070:Poly I-C / Q000276:immunology / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D065631:Rhinitis, Allergic; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology*; D012229:Rhinovirus / Q000276:immunology; D055815:Young Adult; D000095022:Interferon Lambda
chemical_list: D016899:Interferon-beta; D007372:Interferons; D007378:Interleukins; D011070:Poly I-C; D012333:RNA, Messenger; C000624353:interferon-lambda, human; D000095022:Interferon Lambda